AstraZeneca to acquire Alexion EP News Bureau Dec 12, 2020 Subject to approvals, the acquisition is expected to close in Q3 2021
Gennova’s mRNA vaccine candidate for COVID-19 gets DCGI nod for human clinical trials EP News Bureau Dec 12, 2020 It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of…
India prepares for 600 mn COVID vaccine shots; to use standard cold storage: VK Paul Reuters Dec 12, 2020 Serum, Bharat, Zydus, and Sputnik need normal cold chain. I see no problem for these vaccines, he said
US orders additional 100 mn doses of Moderna’s COVID-19 vaccine EP News Bureau Dec 12, 2020 Total of 200 million doses ordered by the US government to date, it retains option to purchase up to an additional 300 million…
US FDA gives EUA for Pfizer/BioNTech COVID-19 vaccine Reuters Dec 12, 2020 The first inoculations would happen early next week
DoP forms five-member technical committee for Phase II PLI scheme Usha Sharma Dec 12, 2020 Dr Eswara Reddy, CDSCO; Dr Amol Kulkarni, NCL, Pune; Prof Arvind Bansal, NIPER Mohali; Satish Khanna, Fullife Healthcare and…
CDSCO to identify and set up two additional facilities for testing COVID-19 vaccines Usha Sharma Dec 11, 2020 The CDSCO has identified the challenges associated with COVID-19 vaccines are taking steps to mitigate them, informs Dr Eswara…
Cipla settles patent litigation of Revlimid (lenalidomide) capsules with Celgene EP News Bureau Dec 11, 2020 Celgene has agreed to provide Cipla with a license to Celgene’s patents required to manufacture and sell certain volume-limited…
New therapies will overcome unmet needs in hepatocellular carcinoma: GlobalData EP News Bureau Dec 11, 2020 They have different mechanisms of action and are aiming to meet needs in different treatment settings
ImmunityBio COVID-19 vaccine candidate shows protection of airways in non-human primates EP News Bureau Dec 11, 2020 The hAd5-COVID-19 candidate is designed to address a potential problem that may emerge when first-generation adenoviral platforms…